Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00381797
Brief Title: Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

First Submitted : September 26, 2006
First Submitted that Met QC Criteria : September 26, 2006
First Posted : September 28, 2006 (Estimate)

Results First Submitted : January 17, 2012
Results First Submitted that Met QC Criteria : January 14, 2013
Results First Posted : January 15, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : October 23, 2017
Last Update Posted : November 28, 2017